Clinical outcomes and complications of single anastomosis duodenal-ileal bypass with sleeve gastrectomy: A 2-year follow-up study in Bogotá, Colombia

Figure 3 Frequency distribution of laboratory results taken before surgery (T1), at 6 mo (T2), and at one year (T3) of follow-up. A: The median hemoglobin was 14.35 mg/dL [interquartile range (IQR) 1.82] at T1, 13.47 mg/dL (IQR 2.6) at T2, and 13.50 mg/dL (1.37) at T3; B: The median hematocrit was 44.36% (IQR 5.17) at T1, 30.27% (IQR 6.5) at T2, and 40.22% (3.33) at T3; C: Median glycated hemoglobin was 5.81% (IQR 0.75) at T1, 5.1% (IQR 0.48) at T2, and 13.50% (IQR 0.51) at T3; D: Median glucose levels were 97.54 mg/dL (IQR 21.07) at T1, 81.7 mg/dl (IQR 10.99) at T2, and 79 mg/dL (IQR 10.9) at T3; E: Median TSH levels were 2.8 mU/L at T1, 2.10 mU/L at T2, and 2.46mU/L at T3 ; F: Cholesterol at T1 of 179.80 mg/dL (IQR 48.9) dropped at T2 to 143.38 mg/dL (IQR 46) and was maintained at T3 at 143.13 mg/dL (IQR 26); G: High-density lipoprotein levels (HDL) went from 44.1 mg/dL (IQR 10.9) at T1 to 41.35 mg/dL (IQR 12.45) at T2 and 46.5 mg/dL (IQR 13) at T3; H: LDL levels went from 108 mg/dL (IQR 39.6) at T1 to 89.4 mg/dL (IQR 36.31) at T2 and 84.37 mg/dL (IQR 37.67) at T3; I: Triglyceride levels went from 110.8 mg/dL (IQR 64.75) at T1 to 90 mg/dL (IQR 46.09) at T2 and 75.5 mg/dL (IQR 25.8) at T3. T1: Preoperative, T2: 6 mo, T3: 1 year. ^aP < 0.05, ^bP < 0.01, ^cP < 0.01, ^dP < 0.00001. NS: Not significant.